Stay updated with breaking news from Protembo System. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Protembis GmbH (Protembis), a privately-held emerging cardiovascular medical device company, announced today the completion of a ? 30 million Series B financing round to support the enrollment of the PROTEMBO Investigational Device Exemption (IDE)...
Cardiovascular medical device maker Protembis announced today that it completed a $32.6 million (€30 million) Series B financing round.
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
AACHEN, Germany, August 29, 2023--Protembis GmbH (Protembis) a privately-held emerging cardiovascular medical device company, announced today the appointment of Professor J Mocco MD, MS, FAANS, FAHA of Icahn School of Medicine at Mount Sinai, NY, USA as an independent member of their Board of Directors.
Leadership team reinforced for next phase in Protembis' clinical and regulatory growth trajectory Protembis GmbH, a privately-held emerging cardiovascular medical device company, announced today